Erratum to: Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Jennifer Grosjean-Raillard; Lionel Adès; Simone Boehrer; Maximilien Tailler; Claire Fabre; Thorsten Braun; Stéphane de Botton; Alain Israël; Pierre Fenaux; Guido Guido Kroemer

doi:10.1007/s10495-015-1154-9

Back

Erratum to: Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Corrigendum 2015 en

Related publications

Article2008

Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Jennifer Grosjean-Raillard, Lionel Adès, Simone Boehrer, Maximilien Tailler, Claire Fabre, Thorsten Braun, Stéphane de Botton, Alain Israël, Pierre Fenaux, Guido Guido Kroemer

Article2007

Flt3 Receptor Inhibition Abolishes Constitutive NFκB Activation in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.

J. Grosjean, Lionel Adès, Simone Bohrer, Pierre Fenaux, Guido Guido Kroemer

Article2008

ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Jennifer Grosjean-Raillard, Maximilien Tailler, Lionel Adès, Jean‐Luc Perfettini, Claire Fabre, Thomas Braun, Stéphane de Botton, Pierre Fenaux, Guido Guido Kroemer

Article2007

NF-κB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia

Claire Fabre, G Carvalho, Ezgi Tasdemir, Thomas Braun, Lionel Adès, J. Grosjean, Simone Boehrer, David Métivier, Sylvie Souquère, Gérard Pierron, Pierre Fenaux, Guido Guido Kroemer

Article2006

Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia

G Carvalho, Claire Fabre, Thomas Braun, J. Grosjean, Lionel Adès, Fabrice Agou, Ezgi Tasdemir, Simone Boehrer, Alain Israël, M. Véron, Pierre Fenaux, Guido Guido Kroemer

Erratum to: Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Discussion(0)

Related publications

Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Flt3 Receptor Inhibition Abolishes Constitutive NFκB Activation in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.

ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

NF-κB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia

Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia